| Compounds | Proteomics method | | ROS | Effects | Mechanism of action | Cell lines | References |
| Sesquiterpene |
| -Elemene | iTRAQ | N/A | N/A | N/A | Ribosome signaling, PPARs signaling, actin cytoskeleton, phagosome, biosynthesis, and amino acids metabolism | SGC7901 | [23] |
| β-Elemene | N/A | | | Apoptosis↑ | Release of cytochrome c/caspase-3 | A549/DDP | [20] |
| δ-Elemene | N/A | | N/A | Apoptosis↑ | p38 MAPK | NCI-H292 | [97] |
| β-Elemene | N/A | | | Apoptosis↑ | Release of cytochrome c/caspase-3/caspase-8/caspase-9 | A2780/CP MCAS | [21] |
| β-Elemene | N/A | N/A | N/A | Apoptosis↑ | Release of cytochrome c/caspase-3/caspase-8/caspase-9, p53 | H23, H358, H460, and A549 | [19] |
| Deoxyelephantopin | 2-DE DIGE | N/A | N/A | Apoptosis↑ | ER stress-independent apoptotic pathway | TS/A | [27] |
| Deoxyelephantopin | N/A | | | Apoptosis↑ | Release of cytochrome c/caspase-3/caspase-7/caspase-8/caspase-10, Akt, ERK, and JNK pathways | CNE | [25] |
| Isodeoxyelephantopin | SILAC | | | Apoptosis↑ | ROS-dependent DNA damage, mitochondrial-mediated apoptosis, and antitumor inflammation factor pathway | CNE1 | [14] |
| Isodeoxyelephantopin | N/A | N/A | N/A | Apoptosis↑ | NF-κB | HL60, H1299, MM.1S, U266, and KBM-5 | [82] |
| Diterpene |
| Celastrol | SILAC | | | Apoptosis↑ Proliferation↓ | Stress response, oxidative stress, and effects | Lymphoblastoid cells | [98] |
| Triptolide | 2-DE | N/A | N/A | Proliferation↓ | Perinuclear translocation of 14-3-3 | SW480 and Lovo | [36] |
| Triptolide | N/A | | | Apoptosis↑ | Release of cytochrome c/Smac/diablo, activation of caspase-3/caspase-9 | HS-sultan, IM9, RPMI8226, and U266 | [38] |
| Triptolide | N/A | | | Apoptosis↑ | Release of cytochrome c, caspase-3/caspase-9, Bcl-2↓, Bax, and p53↑ | L-02 | [40] |
| Tanshinone IIA | 2-DE | | | Apoptosis↑ | p38, JNK/IRE1/PERK pathways, and ROS/ER stress pathways | CaSki | [99] |
|
|